The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Self-citationUnique features of long non-coding RNA biogenesis and function
Quinn, J. J., & Chang, H. Y. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.10 · Cited by 3,672
Long Noncoding RNAs in Cancer Pathways
Schmitt, A. M., & Chang, H. Y. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.010 · Cited by 2,992
Modular regulatory principles of large non-coding RNAs
Guttman, M., & Rinn, J. L. (2012) · Nature · doi:10.1038/nature10887 · Cited by 2,265
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
“The human and mouseand Carol W. Greider1,6,8 telomerase RNA components have been cloned (Blasco1Cold Spring Harbor Laboratory et al., 1995; Feng et al., 1995), and one protein associ-PO Box 100 ated with mammalian telomerase was identified recentlyCold Spring Harbor, New York 11724 (Harrington et…”
BackgroundSelf-citationNon-coding RNA networks in cancer
Anastasiadou, E., Jacob, L. S., & Slack, F. J. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.99 · Cited by 1,884
The hallmarks of cancer: A long non-coding RNA point of view
Gutschner, T., & Diederichs, S. (2012) · RNA Biology · doi:10.4161/rna.20481 · Cited by 1,802
How Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802
“A complex of four proteins (GAR1, NHP2, NOP10, and the putative pseudouridine synthase dyskerin) associates with snoRNAs to form small nucleolar ribonucleoprotein particles (snoRNPs), and the binding of this complex to the H/ACA domain of TERC may have a role in the biogenesis of the telomerase RNP (134).”
BackgroundInfluentialMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
“Eventu- ally, the proliferation of cultured human cells will halt at crease with tumor progression (Feng et al., 1995; Blasco et al., 1996; Broccoli et al., 1996; Soder et al., 1997), thea point termed senescence (Hayflick and Moorhead, 1961; Goldstein, 1990), apparently before the telomeres…”
InfluentialOn the classification of long non-coding RNAs
Ma, L., Bajic, V. B., & Zhang, Z. (2013) · RNA Biology · doi:10.4161/rna.24604 · Cited by 1,327
“89 In ciliated protozoa, maternal RNA templates have been found to guide reproducible rearrangement during the transition from germline nucleus to somatic nucleus.”
BackgroundEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
Self-citationReverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Control of telomere length by the human telomeric protein TRF1
van Steensel, B., & de Lange, T. (1997) · Nature · doi:10.1038/385740a0 · Cited by 1,219
Aubert, G., & Lansdorp, P. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00026.2007 · Cited by 1,188
“33 and telomerase RNA containing 451 nucleotides (including the CAAUCCCAAUC telomere template) encoded by the telomerase RNA gene hTERC (74), located on chromosome 3q21-q28 (see Figs.”
BackgroundA telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
“PCR amplification of telomerase products synthesized with the altered template generates a single product instead of the wild-type 6-base-pair (bp) ladde”
MethodDickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Inhibition of telomerase limits the growth of human cancer cells
Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., & Weinberg, R. A. (1999) · Nature Medicine · doi:10.1038/13495 · Cited by 1,030
“is composed minimally of a constitutively expressed, template-containing RNA subuni”
BackgroundArmanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 766
Self-citationThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944
Telomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924
Human Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
“In humans, hTR is transcribed by RNA polymerase II and is processed at its 3 end to produce a mature transcript of 451 nucleotides (64).”
BackgroundTelomeres: Beginning to Understand the End
Zakian, V. A. (1995) · Science · doi:10.1126/science.270.5242.1601 · Cited by 852
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Regulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798
Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970199z · Cited by 794
Hayflick, his limit, and cellular ageing
Shay, J. W., & Wright, W. E. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036093 · Cited by 764
Normal human chromosomes have long G-rich telomeric overhangs at one end
Wright, W. E., Tesmer, V. M., Huffman, K. E., Levene, S. D., & Shay, J. W. (1997) · Genes & Development · doi:10.1101/gad.11.21.2801 · Cited by 734
“Eliminating the RNA component of telomerase prevents this activity and results in telomere shortening in organisms ranging from yeast to humans (Singer and Gottschling 1994; Blasco et al. 1995; Feng et al. 1995).”
BackgroundSenescence and immortalization: Role of telomeres and telomerase
Shay, J. W., & Wright, W. E. (2005) · Carcinogenesis · doi:10.1093/carcin/bgh296 · Cited by 610
Telomeres in cancer: tumour suppression and genome instability
Maciejowski, J., & de Lange, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.171 · Cited by 745
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
Self-citationMcEachern, M. J., Krauskopf, A., & Blackburn, E. H. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.331 · Cited by 716
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Protein Composition of Catalytically Active Human Telomerase from Immortal Cells
Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J., & Reddel, R. R. (2007) · Science · doi:10.1126/science.1138596 · Cited by 669
A Mammalian Telomerase-Associated Protein
Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Program, A. E., Bass, M. B., Arruda, I., & Robinson, M. O. (1997) · Science · doi:10.1126/science.275.5302.973 · Cited by 663
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637
“, 1997) and the human telomerase RNA component (hTERC) (Feng et al., 1995).”
BackgroundTelomere maintenance as a target for anticancer drug discovery
Neidle, S., & Parkinson, G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd793 · Cited by 624
“cgi?l=7012">hTR in humans) within the telomerase comple”
BackgroundLNA: a versatile tool for therapeutics and genomics
Petersen, M., & Wengel, J. (2003) · Trends in Biotechnology · doi:10.1016/s0167-7799(02)00038-0 · Cited by 613
Cdc13p: A Single-Strand Telomeric DNA-Binding Protein with a Dual Role in Yeast Telomere Maintenance
Nugent, C. I., Hughes, T. R., Lue, N. F., & Lundblad, V. (1996) · Science · doi:10.1126/science.274.5285.249 · Cited by 598
Secondary Structure of Vertebrate Telomerase RNA
Chen, J.-L., Blasco, M. A., & Greider, C. W. (2000) · Cell · doi:10.1016/s0092-8674(00)80687-x · Cited by 605
“RNAs are Feng et al., 1995).”
Self-citationTelomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
Nakayama, J.-I., Tahara, H., Tahara, E., Saito, M., Ito, K., Nakamura, H., Nakanishi, T., Nakanishi, E., Ide, T., & Ishikawa, F. (1998) · Nature Genetics · doi:10.1038/ng0198-65 · Cited by 467
(1999) · PubMed
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P. K., Duncan, E. L., Reddel, R. R., & Jefferson, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 585
“Genes for the RNA component (27,28) and for a protein homologous to the p80 component of Tetrahymena telomerase (29,30) have been cloned.”
BackgroundFunctional requirement of p23 and Hsp90 in telomerase complexes
Holt, S. E., Aisner, D. L., Baur, J., Tesmer, V. M., Dy, M., Ouellette, M., Trager, J. B., Morin, G. B., Toft, D. O., Shay, J. W., et al. (1999) · Genes & Development · doi:10.1101/gad.13.7.817 · Cited by 539
“…a ribonucleoprotein that uses the complementary sequence in its associated RNA as a template for a reverse transcription reaction that adds telomeric repeats to the ends of chromosomes (Greider and Blackburn 1989; Feng et al. 1995; Lingner et al. 1997; Meyerson et al. 1997; Nakamura et al. 1997).”
BackgroundMethodInfluentialHerbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Telomestatin, a Novel Telomerase Inhibitor from Streptomyces anulatus
Shin-ya, K., Wierzba, K., Matsuo, K.-I., Ohtani, T., Yamada, Y., Furihata, K., Hayakawa, Y., & Seto, H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005780q · Cited by 509
Shay, J. W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.677 · Cited by 509
“The 5′ end of hTR contains the template used for the addition of telomeric sequences to the ends of the chromosomes (37,83), as well as a pseudoknot that is likely to be important for telomerase function (81,84).”
BackgroundA Box H/ACA Small Nucleolar RNA-Like Domain at the Human Telomerase RNA 3′ End
Mitchell, J. R., Cheng, J., & Collins, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.567 · Cited by 510
Estrogen activates telomerase.
Kyo, S., Takakura, M., Kanaya, T., Zhuo, W., FUJIMOTO, K., Nishio, Y., Orimo, A., & Inoue, M. (1999) · PubMed · Cited by 596
Lendvay, T. S., Morris, D. K., Sah, J., Balasubramanian, B., & Lundblad, V. (1996) · Genetics · doi:10.1093/genetics/144.4.1399 · Cited by 503
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
“Telomerase functions by adding TTAGGG repeats onto the telomeres using its intrinsic RNA as a template for reverse transcription (Feng et al., 1995).”
BackgroundTelomere Position Effect in Human Cells
Baur, J. A., Zou, Y., Shay, J. W., & Wright, W. E. (2001) · Science · doi:10.1126/science.1062329 · Cited by 479
Kyo, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.669 · Cited by 494
Kang, S. S., Kwon, T., Kwon, D. Y., & Do, S. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13085 · Cited by 480
Hayflick, L. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00023-0 · Cited by 466
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
Herrera, E., Samper, E., Martín‐Caballero, J., Flores, J. M., Lee, H., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.2950 · Cited by 471
“Disease states associated with telomerase deficiency appear earlier in mice with short telomeres”
BackgroundHuman telomerase contains evolutionarily conserved catalytic and structural subunits
Harrington, L., Zhou, W., McPhail, T., Oulton, R., Yeung, D. S. K., Mar, V., Bass, M. B., & Robinson, M. O. (1997) · Genes & Development · doi:10.1101/gad.11.23.3109 · Cited by 465
“The RNA component of telomerase has been cloned in several organisms, including ciliates, yeast, human, and mouse (Greider and Blackburn 1989; Shippen-Lentz and Blackburn 1990; Romero and Blackburn 1991; Lingner et al. 1994; Blasco et al. 1995; Feng et al. 1995; McEachern and Blackburn 1995; Singer and Gottschling 199…”
BackgroundGomes, N. M. V., Ryder, O. A., Houck, M. L., Charter, S. J., Walker, W., Forsyth, N. R., Austad, S. N., Venditti, C., Pagel, M., Shay, J. W., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00718.x · Cited by 464
TERT promoter mutations in thyroid cancer
Liu, R., & Xing, M. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0533 · Cited by 441
“Compared with the RNA subunit, TERT plays a dominant role in the activation of telomerase during malignant transformation of cells (Feng et al. 1995, Meyerson et al. 1997, Bodnar et al. 1998, Hahn et al. 1999, Janknecht 2004).”
BackgroundWheelhouse, R. T., Sun, D., Han, H., Han, F. X., & Hurley, L. H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973792e · Cited by 448
Role of Oxidative Stress in Telomere Length Regulation and Replicative Senescence
VON ZGLINICKI, T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06639.x · Cited by 445
Telomerase therapeutics for cancer: challenges and new directions
Shay, J. W., & Wright, W. E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2081 · Cited by 432
The telomerase reverse transcriptase: components and regulation
Nugent, C. I., & Lundblad, V. (1998) · Genes & Development · doi:10.1101/gad.12.8.1073 · Cited by 438
“…ciliates are so diverged that, with the exception of the template region and an adjacent short region, the primary sequences cannot be aligned readily (Lingner et al. 1994), and even the murine and human RNA subunits show only 65% sequence identity (Blasco et al. 1995; Feng et al. 1995).”
BackgroundPIK3CA as an oncogene in cervical cancer
Ma, Y.-Y., Wei, S.-J., Lin, Y.-C., Lung, J.-C., Chang, T.-C., Whang-Peng, J., Liu, J. M., Yang, D.-M., Yang, W. K., & Shen, C.-Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203597 · Cited by 434
“In addition to PIK3CA, another possible gene within the 3q amplicon is hTR, which encodes the RNA component of human telomerase (Feng et al., 1995).”
BackgroundMethodPreferential Accumulation of Single-Stranded Regions in Telomeres of Human Fibroblasts
Petersen, S., Saretzki, G., & Zglinicki, T. V. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3893 · Cited by 427
Beginning to Understand the End of the Chromosome
Cech, T. R. (2004) · Cell · doi:10.1016/s0092-8674(04)00038-8 · Cited by 421
A highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Telomerase Activity in Human Breast Tumors
Hiyama, E., Gollahon, L., Kataoka, T., Kuroi, K., Yokoyama, T., Gazdar, A. F., Hiyama, K., Piatyszek, M. A., & Shay, J. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.2.116 · Cited by 423
“Telomerase contains an RNA component that has a template region complementary to (TTAGGG)n repeats that permits the de novo synthesis of TTAGGG telomeric DNA onto chromosomal ends ( 17-19 ).”
BackgroundCdc13 Delivers Separate Complexes to the Telomere for End Protection and Replication
Pennock, E., Buckley, K., & Lundblad, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00226-4 · Cited by 412
Telomerase and DNA End Replication: No Longer a Lagging Strand Problem?
Lingner, J., Cooper, J. P., & Cech, T. R. (1995) · Science · doi:10.1126/science.7545310 · Cited by 396
Regulated expression of telomerase activity in human T lymphocyte development and activation.
Weng, N. P., Levine, B. L., June, C. H., & Hodes, R. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2471 · Cited by 403
“The recent cloning of genes that encode the R N A template components o f human and mouse telomerase will allow the study of the regulation of telomerase R N A template expression, as well as the determination o f the telomerase function in lymphocytes (45, 46).”
BackgroundCloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
Horikawa, I., Cable, P. L., Afshari, C. A., & Barrett, J. C. (1999) · PubMed · Cited by 446
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
Kolquist, K. A., Ellisen, L. W., Counter, C. M., Meyerson, M. M., Tan, L. K., Weinberg, R. A., Haber, D. A., & Gerald, W. L. (1998) · Nature Genetics · doi:10.1038/554 · Cited by 382
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
Zhu, J., Wang, H., Bishop, J. M., & Blackburn, E. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3723 · Cited by 381
Shi, S., Gronthos, S., Chen, S., Reddi, A., Counter, C. M., Robey, P. G., & Wang, C.-Y. (2002) · Nature Biotechnology · doi:10.1038/nbt0602-587 · Cited by 376
“Telomerase contains an RNA component, which provides the template for the synthesis of TTAGGG repeats, and protein components including the catalytic subunit hTER”
BackgroundTelomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundNakayama, J.-I., Saito, M., Nakamura, H., Matsuura, A., & Ishikawa, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81933-9 · Cited by 376
Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes
van Heesch, S., van Iterson, M., Jacobi, J., Boymans, S., Essers, P. B., de Bruijn, E., Hao, W., MacInnes, A. W., Cuppen, E., & Simonis, M. (2014) · Genome Biology · doi:10.1186/gb-2014-15-1-r6 · Cited by 365
“The importance of noncoding RNA transcripts for key cellular functions has been well established by studies on for example XIST [1], which acts in X-chromosome silencing, and TERC [2], which functions in telomeric maintenance.”
BackgroundGonzález‐Suárez, E., Samper, E., Ramírez, A., Flores, J. M., Martín‐Caballero, J., Jorcano, J. L., & Blasco, M. A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2619 · Cited by 372
Regulation of human telomerase in homeostasis and disease
Roake, C. M., & Artandi, S. E. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0234-z · Cited by 346
Natural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
“This key experiment demonstrated that hTR was indeed the RNA component of telomerase (12).”
BackgroundMethodInfluentialTelomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
Reconstitution of human telomerase activity in vitro
Beattie, T. L., Zhou, W., Robinson, M. O., & Harrington, L. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70067-3 · Cited by 286
“The numbers refer to the positions of nucleotides within hTR [13].”
InfluentialInhibition of human telomerase activity by peptide nucleic acids
Norton, J. C., Piatyszek, M. A., Wright, W. E., Shay, J. W., & Corey, D. R. (1996) · Nature Biotechnology · doi:10.1038/nbt0596-615 · Cited by 343
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
Telomere length homeostasis requires that telomerase levels are limiting
Cristofari, G., & Lingner, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600952 · Cited by 314
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
“Telomere sequences can be restored by a ribonucleoprotein called telomerase by adding TTAGGG repeats onto the telomeres using its intrinsic RNA, TERC, as a template for reverse transcription [69].”
BackgroundZhang, Z., Yang, X., Zhang, Y., Zeng, B., Wang, S., Zhu, T., Roden, R. B. S., Chen, Y., & Yang, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2831 · Cited by 317
Self-citationHodes, R. J., Hathcock, K. S., & Weng, N.-P. (2002) · Nature Reviews Immunology · doi:10.1038/nri890 · Cited by 309
“cgi?l=7012">TR ) that encodes telomeric DNA repeat”
Constitutive telomerase expression promotes mammary carcinomas in aging mice
Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112515399 · Cited by 317
Syndromes of Telomere Shortening
Armanios, M. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150046 · Cited by 317
Telomere maintenance and disease
Wong, J. M., & Collins, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14369-3 · Cited by 313
Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice
Hande, M. P., Samper, E., Lansdorp, P., & Blasco, M. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.589 · Cited by 313
“, 1998), an RNA molecule that contains the template for the synthesis of telomeric repeats (Greider and Blackburn, 1989; Singer and Gottschling, 1994; Blasco et al., 1995; Feng et al., 1995; McEachern and Blackburn, 1995), and other associated proteins (Collins et al.”
Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303
“, 1997), an RNA domain (hTR) (Feng et al., 1995), and a further protein (TEP-1) (Harrington et al.”
The Pin2/TRF1-Interacting Protein PinX1 Is a Potent Telomerase Inhibitor
Zhou, X. Z., & Lu, K. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00538-4 · Cited by 309
Human telomerase: biogenesis, trafficking, recruitment, and activation
Schmidt, J. C., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.263863.115 · Cited by 301
“Unlike scaRNAs and snoRNAs, whose precursors are contained in intronic regions of mRNAs, hTR is transcribed from its own promoter by RNA polymerase II (Feng et al. 1995).”
BackgroundAntitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
Hu, J., Hwang, S. S., Liesa, M., Gan, B., Sahin, E., Jaskelioff, M., Ding, Z., Ying, H., Boutin, A. T., Zhang, H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.028 · Cited by 296
“In the absence of 4-OHT, mice homozygous for TERT ER (designated TERT ER/ER ) are telomerase activity deficient and sustain same cytogenetic and cellular phenotypes of conventional TERT or TERC knockout model (Jaskelioff et al., 2011).”
Telomerase and the maintenance of chromosome ends
Bryan, T. M., & Cech, T. R. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80043-x · Cited by 301
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.
Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., & Inoue, M. (1998) · PubMed · Cited by 317
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.